Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
China Journal of Chinese Materia Medica ; (24): 2674-2678, 2015.
Article in English | WPRIM | ID: wpr-284756

ABSTRACT

The study focused on the therapeutic efficacy of Tibetan medicines on cerebral ischemia. The combined medication methods and administration habits in clinic for more than 10 years were simulated. Three typical Tibetan medicines, i.e., 25-Herb Shanhu pill, Wishful-Treasure pill and 20-Herb Chenxiang pill, were administered to the animal model of permanent middle cerebral artery occlusion in the morning, noon and evening, respectively. On the second day after the final administration, the activity of serum oxidative stress marker SOD and the content of MDA were evaluated. Infarct volumes were quantified through TTC staining. Inflammatory reaction maker NF-kappaB p65 gene and apoptosis. makers Bax and Cyct were selected to study the molecular mechanism of combined herbs with the immunohistochemistry technique. According to the result, the respective combination of 25-Herb Shanhu pill, Wishful-Treasure pill and 20-Herb Chenxiang pill in the morning, noon and evening showed unique advantages in reducing the damage of oxidative stress, infarct volumes, encephaledema caused by ischemia, inflammatory factor aggregation and inhibiting apoptosis, with consistent therapeutic efficacies in clinic.


Subject(s)
Animals , Male , Rats , Brain Ischemia , Drug Therapy , Metabolism , Lipid Peroxidation , Medicine, Tibetan Traditional , Superoxide Dismutase , Metabolism , Time Factors , Transcription Factor RelA , Physiology
2.
China Journal of Chinese Materia Medica ; (24): 4020-4023, 2013.
Article in Chinese | WPRIM | ID: wpr-287648

ABSTRACT

Aggregation and accumulation of beta-amyloid peptide (Abeta) in brain tissues contribute to the pathogenesis of Alzheimer's disease. Therefore, the promotion of Abeta clearance is one of the key targets for preventing and treatment Alzheimer's disease. Studies proved that some traditional Chinese medicine (TCM) compounds and extracts could impact the activity of degrading enzyme in amyloid peptide, the transport of hemato encephalic barrier and the phagocytosis of microglial cells, promote Abeta clearance, and improve learning and memory of animal models with Alzheimer's disease. In this review, we made an summary for the relations between Abeta and Alzheimer's disease, the Abeta clearance mechanism and the clearance effect of traditional Chinese medicines.


Subject(s)
Animals , Humans , Alzheimer Disease , Drug Therapy , Metabolism , Pathology , Amyloid beta-Peptides , Chemistry , Metabolism , Blood-Brain Barrier , Metabolism , Medicine, Chinese Traditional , Methods , Microglia , Metabolism , Protein Multimerization
SELECTION OF CITATIONS
SEARCH DETAIL